Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03629535 · ClinicalTrials.gov registry record · NA

Accuracy of Non-invasive Non-oscillometric Blood Pressure Wristband

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
8
Enrollment target

NCT03629535: Completed NA study, sponsored by NYU Langone Health.

NCT03629535 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03629535, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target

Study Summary

The primary objective of the present investigation is to determine the accuracy of a non-invasive non-oscillometric blood pressure wristband device when compared to invasive intra-arterial blood pressure monitors. In an intensive care unit patients who already have an intra-arterial blood pressure monitor in place, this wristband device will be applied and blood pressure readings compared for approximately 15 minutes. Blood pressure readings will be gathered and compared.

Primary Outcome

If the value obtained from the LiveMetric determination lied within the range of the reference BP, an error of 0 mm Hg (0kPa) was assigned to this determination. If the value obtained from the LiveMetric determination lies outside the range of the reference BP, the value of the determination from the adjacent limit of the range of the variation of BP was subtracted. That difference represents the error for this determination. The arithmetic mean of the error is calculated and its experimental s

Interventions

  • DEVICE Non-invasive non-oscillometric blood pressure wristband device
  • DEVICE Invasive intra-arterial blood pressure monitors.

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2019-04-01
Est. Completion 2019-09-10
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT03629535 record still lists

NCT03629535 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Non-invasive non-oscillometric blood pressure wristband device is the first listed.

NCT03629535 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03629535 about?

NCT03629535 is a clinical study titled "Accuracy of Non-invasive Non-oscillometric Blood Pressure Wristband". The primary objective of the present investigation is to determine the accuracy of a non-invasive non-oscillometric blood pressure wristband device when compared to invasive intra-arterial blood pressure monitors. In an intensive care unit patients who already have an intra-arterial blood pressure m...

What is the current status of trial NCT03629535?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2019-04-01. Estimated completion is 2019-09-10.

What interventions are being tested in trial NCT03629535?

The interventions under investigation include: Non-invasive non-oscillometric blood pressure wristband device (DEVICE), Invasive intra-arterial blood pressure monitors. (DEVICE).

Who is sponsoring clinical trial NCT03629535?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03629535's enrollment target sits among peer trials

8 1976th of 2000 higher than 19 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03629535, the US trial registry maintained by the National Library of Medicine. NCT03629535 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.